Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

118.10 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
News headline image
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
From Merck & Co., Inc.
Via Business Wire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
Via Investor Brand Network
News headline image
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
Via The Motley Fool
Topics Stocks
News headline image
Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report ↗
Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies . 
Via Benzinga
Topics Government
News headline image
2 S&P 500 Stocks with Promising Prospects and 1 to Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday. 
Via Chartmill
News headline image
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment ↗
Via Benzinga
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗
 
Via Benzinga
News headline image
Merck's Hypertension Drug On FDA Fast Track For Label Expansion ↗
Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact. 
Via Benzinga
News headline image
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
From Merck & Co., Inc.
Via Business Wire
News headline image
MERCK & CO. INC. (NYSE:MRK) – A Strong Value Candidate in Healthcare ↗
MERCK & CO. (NYSE:MRK) is an undervalued pharmaceutical stock with strong profitability, a healthy balance sheet, and a reliable dividend, making it a candidate for value investors. 
Via Chartmill
News headline image
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3% ↗
The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields. 
Via Benzinga
Topics Stocks
News headline image
Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank? ↗
The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive. 
Via Benzinga
Topics Stocks
News headline image
Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29
From Merck & Co., Inc.
Via Business Wire
News headline image
HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best? ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment? ↗
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide. 
Via Investor's Business Daily
News headline image
Peering Into Merck & Co's Recent Short Interest ↗
 
Via Benzinga
News headline image
1 Profitable Stock to Consider Right Now and 2 to Think Twice About
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
3 Absurdly Cheap Stocks Ready for a Breakout ↗
All three stocks are poised to go higher. 
Via The Motley Fool
News headline image
RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants ↗
CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials. 
Via Benzinga
News headline image
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm ↗
The panel also voted to recommend Merck’s RSV antibody drug Enflonsia for newborns whose mothers didn’t receive prenatal protection. 
Via Stocktwits
News headline image
5 Biotech Stocks with Highly Anticipated Pending Results ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise ↗
Elanco upgraded to Outperform by William Blair as pipeline gains traction and EMA backs Zenrelia ahead of expected Q3 approval. 
Via Benzinga
News headline image
ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Stocks Too Cheap to Ignore at These Prices ↗
Via The Motley Fool
Topics Artificial Intelligence Lawsuit
News headline image
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group ↗
Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts. 
Via Benzinga
News headline image
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck's Hypertension Drug Cuts Clinical Worsening Risk In Over 70% Of Patients On Double Background Therapy ↗
Merck's Winrevair reduced clinical worsening in PAH patients in the Phase 3 HYPERION trial, building on prior positive study outcomes. 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.